Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Intercure Ltd. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 15 | 19 | +4 |
| Shares | 2.48M | 2.49M | +10.2K (+0.4%) |
| Value | $3.50M | $3.68M | +$177.3K (+5.1%) |
New holders (6)
Institutions that held Intercure Ltd. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Revisor Wealth Management LLC | 12,648 | $20.2K | 0.01% |
| UBS Group AG | 8,239 | $12.1K | 0.00% |
| Founders Capital Management | 7,000 | $10.3K | 0.01% |
| Bank of America Corp | 2,054 | $3.02K | 0.00% |
| Advisor Group Holdings, Inc. | 150 | $220 | 0.00% |
| Simplex Trading, LLC | 240 | $0 | 0.00% |
Sold out (2)
Institutions that held Intercure Ltd. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Jane Street Group, LLC | 15,933 | $22.4K |
| Squarepoint Ops LLC | 11,268 | $15.8K |